IGF2BP2 and Hepatic fibrosis: Zhou et al. reported that insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2), a novel m6A reader, promotes H3K18la via glycolytic regulation to activate HSCs and accelerate liver fibrosis [73].